van ’t Klooster, Cilie C.
van der Graaf, Yolanda
Nathoe, Hendrik M.
Bots, Michiel L.
de Borst, Gert J.
Visseren, Frank L. J.
Leiner, Tim
Asselbergs, F. W.
Nathoe, H. M.
de Borst, G. J.
Bots, M. L.
Geerlings, M. I.
Emmelot, M. H.
de Jong, P. A.
Leiner, T.
Lely, A. T.
van der Kaaij, N. P.
Kappelle, L. J.
Ruigrok, Y. M.
Verhaar, M. C.
Visseren, F. L. J.
Westerink, J.
,
Funding for this research was provided by:
Universitair Medisch Centrum Utrecht
Article History
Received: 17 November 2020
Accepted: 15 January 2021
First Online: 12 February 2021
Compliance with ethical standards
:
: C.C. van ‘t Klooster, Y. van der Graaf, H.M. Nathoe, M.L. Bots, F.L.J. Visseren, T. Leiner declares that they have no conflict of interest. G.J. de Borst has received speaker fees from Bayer AG and Johnson & Johnson.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional board of the UMCU and all study participants provided written informed consent.